Haemonetics Corporation is a healthcare company. The Company is engaged developing and manufacturing automated blood component collection devices and surgical blood salvage devices. The Company offer devices and related consumables, information technology software platforms, and consulting services. Its customers are blood and plasma collectors, hospitals and health care providers globally. The Company has four global product families: plasma, blood center, hospital, and software solutions. Its products include equipment devices and the related disposables used with these devices. Disposables include the plasma, blood center and hospital product families. Plasma consists of the disposables used to perform apheresis for the separation of whole blood components. In August 2012, Pall Corporat... (Source: SEC reports)
Competitor - 1/7
Which company is more competitive with Haemonetics Corporation?
BRAINTREE, Mass., Sept. 14, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced the appointment of David J. Wilson as President, Plasma Business Unit, effective September 18, 2017. [...]
BRAINTREE, Mass., Aug. 29, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at Morgan Stanley\'s Global Healthcare Conference in [...]
BRAINTREE, Mass., June 14, 2017 /PRNewswire/ --Â Haemonetics Corporation (NYSE: HAE) will webcast the management presentations and the question and answer period of its investor and analyst meeting [...]